Medtech Insight's News We're Watching highlights a few noteworthy industry developments you might have missed: Accenture's new Vision Report addresses the future of "more human" tech in health care; Efemoral secures FDA's breakthrough status for its bioresorbable peripheral stent; Impulse Dynamics secures $135m to support its cardiac contractility modulation; PrecisionLife and Metrodora announced a partnership to address chronic diseases including long COVID; Cardio Diagnostics launches its cardiac epigenetic/genetic tests in a Walmart near Chicago.
An Accenture 2024 Technology Visiom Report concludes that most health care leaders expect technology to become “more human.”
The report surveyed 3,450 business leaders across many industries – 6% from health organizations, 3% from medtech companies, and 3% from biopharmaceutical companies